Search results
Results from the WOW.Com Content Network
In the context of a clinical trial, a PI may be an academic working with grants from NIH or other funding agencies, or may be effectively a contractor for a pharmaceutical company working on testing the safety and efficacy of new medicines. [citation needed] There were 20,458 PIs on NIH R01 grants in US biomedical research in 2000. In 2013 ...
R03, the NIH Small Grant Program, not renewable and limited to 2 years, with a maximum of $50k/year. R13, NIH Support for Conferences and Scientific Meetings R15, NIH Academic Research Enhancement Award (AREA), supports small research projects limited to a total of $300k over up to 3 years, at universities in the US that have not received more ...
The CSR organizes the peer review groups or study sections that evaluate the majority (76%) of the research grant applications sent to NIH. [1] It also receives all grant applications for NIH, as well as for some other components of the United States Department of Health and Human Services (DHHS). Since 1946, its mission has remained clear and ...
The CRISP (Computer Retrieval of Information on Scientific Projects) system at NIH has been replaced by the RePORT Expenditures and Results (RePORTER) query tool.CRISP was a fully searchable database of biomedical research projects funded by the U.S. government.
The NIH devotes 10% of its funding to research within its own facilities (intramural research), and gives >80% of its funding in research grants to extramural (outside) researchers. [27] Of this extramural funding, a certain percentage (2.8% in 2014) must be granted to small businesses under the SBIR/STTR program. [ 28 ]
The NIH awarded $77,000,000 in individual grants and over $600,000,000 in institutional training grants in fiscal year 2005 . NRSA awards are mostly given to students working on a Ph.D. or an MD or other medical degree, or to individuals who have just earned one of these degrees and are beginning their careers.
The All of Us Research Program (previously known as the Precision Medicine Initiative Cohort Program [1]) is a research program created in 2015 during the tenure of Barack Obama with $130 million [2] in funding that aims to make advances in tailoring medical care to the individual. [3]
On September 2, 2022, the Schmidt Lab's R21 research grant application was accepted and funded by the NIH's (National Institute of Health) NEI department (National Eye Institute). This grant specifically funded the production of ipRGC circuit manipulation facilities. Schmidt is the PI on two R01 research grants, as well.